| Verifiedfields | changed |
|---|---|
| Verifiedrevid | 408782146 |
| Iupac name | (RS)-5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol |
| Chirality | Racemic mixture |
| Usan | Metaproterenol |
| Tradename | Alupent, Metaprel, Orcibest |
| Medlineplus | a682084 |
| Pregnancy au | A |
| Legal au | S4 |
| Pregnancy us | C |
| Legal us | Rx-only |
| Routes of administration | By mouth, inhalation |
| Bioavailability | 3% if inhaled, 40% if taken orally |
| Metabolism | Gastrointestinal and hepatic |
| Elimination half-life | 6 hours |
| Iuphar ligand | 7250 |
| Cas number | 586-06-1 |
| Atc prefix | R03 |
| Atc suffix | AB03 |
| Pubchem | 4086 |
| Drugbank | DB00816 |
| Chemspiderid | 3944 |
| Unii | 53QOG569E0 |
| Kegg | D08300 |
| Chebi | 82719 |
| Chembl | 776 |
| C | 11 |
| H | 17 |
| N | 1 |
| O | 3 |
| Smiles | Oc1cc(cc(O)c1)C(O)CNC(C)C |
| Stdinchi | 1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3 |
| Stdinchikey | LMOINURANNBYCM-UHFFFAOYSA-N |
| Solubility | 9.7 |
Orciprenaline, also known as metaproterenol, is a bronchodilator used in the treatment of asthma.[1][2] Orciprenaline is a moderately selective β2 adrenergic receptor agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on α adrenergic receptors. The pharmacologic effects of β adrenergic agonist drugs, such as orciprenaline, are at least in part attributable to stimulation through β adrenergic receptors of intracellular adenylyl cyclase, the enzyme which catalyzes the conversion of ATP to cAMP. Increased cAMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from many cells, especially from mast cells.
Adverse effects
More common side effects of metaproterenol include tachycardia and nervousness.[3][4] Additional side effects with >1% incidence include headache, nausea, and tremor.[3] A non-exhaustive list of rare side effects includes other cardiovascular symptoms, dizziness, fatigue, etc.[3][4]
References
- ^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). "DrugBank 3.0: a comprehensive resource for omics research on drugs". Nucleic Acids Res.. 39 (Database issue): D1035-41. doi:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682
- ^ Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). "DrugBank: a knowledgebase for drugs, drug actions and drug targets". Nucleic Acids Res. 36 (Database issue): D901-6. doi:10.1093/nar/gkm958. PMC 2238889. PMID 18048412
- ^ "Metaproterenol Sulfate Syrup, USP". dailymed.nlm.nih.gov. Retrieved 2025-05-04.
- ^ "Metaproterenol Side Effects: Common, Severe, Long Term". Drugs.com. Retrieved 2025-05-04.